Opioid Agonist Therapy Use in Hospital Increased to 5.6 Percent in 2020
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 18, 2023 -- Among hospital encounters for opioid toxicity, opioid agonist therapy (OAT) initiation increased from 2013 to 2020, reaching 5.6 percent, according to a study published online Dec. 18 in CMAJ, the journal of the Canadian Medical Association.
Tina Hu, M.D., from the University of Toronto, and colleagues conducted a retrospective, population-based serial cross-sectional study of hospital encounters for opioid toxicity among patients with opioid use disorder (OUD) between Jan. 1, 2013, and March 31, 2020; 20,702 hospital visits for opioid toxicity were included. The primary outcome was initiation of OAT (methadone, buprenorphine-naloxone, or slow-release oral morphine) within seven days of discharge.
The researchers found that the percentage of visits leading to OAT initiation within seven days increased from 1.7 percent or less (quarter [Q]1 2013) to 5.6 percent (Q1 2020). There was no association observed for publication of the Canadian OUD management guideline in 2018 with a significant increase in these rates (slope change, 0.14 percent).
"The release of a national guideline advocating for buprenorphine-naloxone as first-line therapy did not appear to substantially influence OAT initiation rates, suggesting that additional efforts are needed to improve initiation of OAT in acute care settings," the authors write.
One author disclosed receiving payment for expert testimony from multiple law firms related to individual actions involving opioids; one author is perceived to have an intellectual competing interest.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
American Psychiatric Association, May 4-8
The annual meeting of the American Psychiatric Association was held from May 4 to 8 in New York City, drawing participants from around the world, including clinicians...
Rapid Procedure Noninferior for Extended-Release Naltrexone Initiation
THURSDAY, May 9, 2024 -- For patients with opioid use disorder (OUD), a rapid procedure (RP) is noninferior to a standard procedure for initiation of extended-release (XR)...
321,566 Children Lost a Parent to Drug Overdose in 2011 to 2021
WEDNESDAY, May 8, 2024 -- From 2011 to 2021, an estimated 321,566 children lost a parent to drug overdose in the United States, according to a study published online May 8 in JAMA...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.